Webinar: Introduction to Epidemiology in Vaccines and Related Statistical Methods
- Dates of the new session be communicated soon
Desire Consulting (https://desire-consulting.com/)
> The Teachers
Dominique Rosillon, Ph.D, 35 years epidemiology and biostatistics in various CRO’s and Biopharmaceutical companies.
Emilia Gvozdenović, Ph.D, 7 years of experience in epidemiology and clinical biostatistics in multi-national pharmaceutical companies
> Participation fees (excl. Tax) for part 1 and part 2
Private sector: 350 Euros
Academic or non-profit sector: 200 Euros
Prices include all course material.
> To Register
Please fill the form on the the right to register.
The payment procedure by bank transfer will be communicated in a separate Email.
> About the course
Description of the course:
Epidemiology is the study of the distribution and determinants of diseases in populations, and the application to the control of health problems. Real World Evidence (RWE) is in an expanding development phase in medical research. This Course is an introduction to epidemiological concepts and related statistical methods.
Content of the course:
- What is epidemiology?
History of epidemiology
Epidemiology and Human Subjects Research
Classification of Epidemiological Studies:
- Measurement of Disease Occurrence
- Sampling methods
- Analytic epidemiology
- Cohort Studies
- Case-control Studies (+ variants)
- Cross-sectional Studies
- Ecological Studies
Vaccine effectiveness and Vaccination Impact:
Measurement errors & Confounding
Type of errors
Sensitivity & Specificity
Causal inference in Epidemiology
- Two half-day sessions
Researchers who work or plan to work on epidemiological research projects, particularly in vaccines.
Basic knowledge in statistics is required but no advanced experience in epidemiology is needed.
To register to the Webinar “Introduction in Epidemiology in vaccines and related statistical methods”, please complete and send the below form before <date>. A link to webinar with invitation for the 2 sessions will be sent later.